Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Up – Here’s Why

Shares of Ono Pharmaceutical Co. (OTCMKTS:OPHLF) gapped up prior to trading on Wednesday . The stock had previously closed at $15.22, but opened at $16.30. Ono Pharmaceutical shares last traded at $16.30, with a volume of 300 shares changing hands.

Ono Pharmaceutical Stock Performance

The company has a current ratio of 3.02, a quick ratio of 2.56 and a debt-to-equity ratio of 0.10. The company has a market cap of $7.66 billion, a price-to-earnings ratio of 18.31 and a beta of 0.25. The stock has a 50 day moving average price of $13.91 and a two-hundred day moving average price of $12.38.

Ono Pharmaceutical (OTCMKTS:OPHLF) last released its quarterly earnings data on Monday, February 2nd. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.11. Ono Pharmaceutical had a return on equity of 7.76% and a net margin of 12.29%.The business had revenue of $892.70 million during the quarter, compared to the consensus estimate of $727.58 million.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., founded in 1717 and headquartered in Osaka, Japan, is a research‐based pharmaceutical company specializing in the discovery, development and marketing of innovative therapies. With origins as a traditional pharmacy, Ono has grown into a global biopharmaceutical entity focused on delivering new treatment options across several therapeutic areas, including oncology, immunology, cardiovascular and antiviral diseases. The company conducts comprehensive research programs spanning early drug discovery through to clinical development.

One of Ono’s most recognized products is the immune checkpoint inhibitor nivolumab, marketed in collaboration with Bristol-Myers Squibb under the trade name Opdivo.